Tatiana Zagorodnyaya

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Virus growth during influenza vaccine manufacture can lead to mutations that alter antigenic properties of the virus, and thus may affect protective potency of the vaccine. Different reassortants of pandemic "swine" H1N1 influenza A vaccine (121XP, X-179A and X-181) viruses as well as wild type A/California/07/2009(H1N1) and A/PR/8/34 strains were(More)
  • 1